本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

SPYRE THERAPEUTICS INC

24.36
+0.86003.66%
盤後24.720.3600+1.48%16:50 EST
成交量:72.32萬
成交額:1,764.87萬
市值:18.90億
市盈率:-12.16
高:25.02
開:23.47
低:23.03
收:23.50
52周最高:31.35
52周最低:10.91
股本:7,759.21萬
流通股本:6,382.98萬
量比:1.38
換手率:1.13%
股息:- -
股息率:- -
每股收益(TTM):-2.0036
每股收益(LYR):-3.1802
淨資產收益率:-38.08%
總資產收益率:-30.20%
市淨率:6.32
市盈率(LYR):-7.66

資料載入中...

2024/11/18

[修訂]季度報告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2024/11/18

[修訂]季度報告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2024/11/18

[修訂]季度報告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2024/11/18

重要事件披露

Form 8-K - Current report
2024/11/18

[修訂]年度報告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

重要事件披露

Form 8-K - Current report
2024/11/07

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/07

重要事件披露

Form 8-K - Current report
2024/11/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/10/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/23

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/10/15

重要事件披露

Form 8-K - Current report
2024/10/01

SEC問詢函

Form CORRESP - Correspondence
2024/09/14

SEC問詢函

Form CORRESP - Correspondence
2024/08/08

重要事件披露

Form 8-K/A - Current report: [Amend]